medical disciplines, for example, think of laboratory medicine, radiology,
nuclear medicine
Lebedeva, Anna,
Musina, Lyalya,
Galautdinov, Mars,
Prusakov, Alexey,
Yashin, Anatoly,
Ponamarev, Vladimir (2024) of the
nuclear apparatus. Implantation of BMA promoted inhibition of fibrosis, reduction in the number
Bikbov, Mukharram M.,
Kazakbaeva, Gyulli M.,
Rakhimova, Ellina M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Jonas, Jost B. (2025) -closure glaucoma (P = 0.98),
nuclear cataract (P = 0.07), cortical cataract (P = 0.46), axial length (P = 0
. Among all founded lncRNA-based therapeutics and non-invasive diagnostic tools,
nuclear enriched abundant
LATYPOVA, G.M.,
BYCHENKOVA, M.A.,
KATAYEV, V.A.,
PERFILOVA, V.N.,
TYURENKOV, I.N.,
MOKROUSOV, I.S.,
PROKOFIEV, I.I.,
SALIKHOV, SH.M.,
IKSANOVA, G.R. (2019) ), and
nuclear magnetic resonance spectroscopy (NMRS). To model CHF, L-isoproterenol at a dose of 2.5 mg
CAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) ) phosphorylation and reduced its
nuclear translocation by binding PP1A. Verteporfin, a YAP1 inhibitor decreased Lnc
Bikbov, Mukharram M.,
Zainullin, Rinat M.,
Gilmanshin, Timur R.,
Iakupova, Ellina M.,
Kazakbaeva, Gyulli M.,
Panda-Jonas, Songhomitra,
Tuliakova, Azaliia M.,
Fakhretdinova, Albina A.,
Gilemzianova, Leisan I.,
Jonas, Jost B. (2023) . In the model, HGS was not correlated with prevalence of
nuclear cataract (p=0.38), cortical cataract (p=0